Literature DB >> 27301716

HSP90 Regulation of P2X7 Receptor Function Requires an Intact Cytoplasmic C-Terminus.

Keisuke Migita1, Taku Ozaki2, Shuji Shimoyama2, Junko Yamada2, Yoshikazu Nikaido2, Tomonori Furukawa2, Yuko Shiba2, Terrance M Egan2, Shinya Ueno2.   

Abstract

P2X7 receptors (P2X7Rs) are ATP-gated ion channels that display the unusual property of current facilitation during long applications of agonists. Here we show that facilitation disappears in chimeric P2X7Rs containing the C-terminus of the P2X2 receptor (P2X2R), and in a truncated P2X7R missing the cysteine-rich domain of the C-terminus. The chimeric and truncated receptors also show an apparent decreased permeability to N-methyl-d-glucamine(+) (NMDG(+)). The effects of genetic modification of the C-terminus on NMDG(+) permeability were mimicked by preapplication of the HSP90 antagonist geldanamycin to the wild-type receptor. Further, the geldanamycin decreased the shift in the reversal potential of the ATP-gated current measured under bi-ionic NMDG(+)/Na(+) condition without affecting the ability of the long application of agonist to facilitate current amplitude. Taken together, the results suggest that HSP90 may be essential for stabilization and function of P2X7Rs through an action on the cysteine-rich domain of the cytoplasmic the C-terminus.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301716     DOI: 10.1124/mol.115.102988

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Ligand-independent activation of the P2X7 receptor by Hsp90 inhibition stimulates motor neuron apoptosis.

Authors:  Amy L Strayer; Cassandra N Dennys-Rivers; Karina C Ricart; Narae Bae; Joseph S Beckman; Maria Clara Franco; Alvaro G Estevez
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

2.  Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.

Authors:  Junbin Han; Hui Liu; Chunling Liu; Hongjun Jin; Joel S Perlmutter; Terrance M Egan; Zhude Tu
Journal:  Nucl Med Commun       Date:  2017-05       Impact factor: 1.690

Review 3.  P2X7 Interactions and Signaling - Making Head or Tail of It.

Authors:  Robin Kopp; Anna Krautloher; Antonio Ramírez-Fernández; Annette Nicke
Journal:  Front Mol Neurosci       Date:  2019-08-07       Impact factor: 5.639

Review 4.  Targeting extracellular Hsp90: A unique frontier against cancer.

Authors:  Rebecca A Sager; Farzana Khan; Lorenzo Toneatto; SarahBeth D Votra; Sarah J Backe; Mark R Woodford; Mehdi Mollapour; Dimitra Bourboulia
Journal:  Front Mol Biosci       Date:  2022-08-17

5.  Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice.

Authors:  Yuchun Zuo; Jikai Wang; Fan Liao; Xiaoxin Yan; Jianming Li; Lei Huang; Fei Liu
Journal:  Front Mol Neurosci       Date:  2018-11-06       Impact factor: 5.639

Review 6.  P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?

Authors:  Chris N J Young; Dariusz C Górecki
Journal:  Front Chem       Date:  2018-06-28       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.